A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)
Status:
NOT_YET_RECRUITING
Trial end date:
2030-12-02
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy of crovalimab compared with placebo as an add-on therapy to vitamin K antagonist (VKA) in participants with APS.